Our Trustees

Our Board of Trustees is the governing body of Parkinson's UK and is ultimately responsible for everything we do and how we do it.

The Board directs the affairs of the charity, ensuring that we are solvent, well run, and deliver charitable outcomes for the benefit of people affected by Parkinson's.

Mark Goodridge.jpg

Mark Goodridge (Chair)

Mark Goodridge was appointed to the Parkinson's UK Board of Trustees in September 2009. He became Vice Chair in November 2013 and Chair in December 2015.

Mark enjoyed a successful business career in the steel and petrochemical industries and is a former partner at Ernst and Young. Mark has run his own company for over 30 years, advising firms on improving their organisational effectiveness.

He has worked extensively with the boards and executive teams of not for profit, government and public organisations. Mark's work with charities has included Barrow Cadbury Trust, RSPB, Children in Need, The Carbon Trust, Energy Saving Trust and various housing trusts.

Mark also chairs the Board of Governors of a secondary school and advises the Woolf Institute in Cambridge for the study of relations between Jews, Christians and Muslims.

Mary Whyham.jpg

Mary Whyham MBE (VICE CHAIR)

Mary Whyham MBE was elected as a Trustee in September 2015, and became Vice Chair in December 2015. She is also the Chair of our Blackpool, Fylde and Wyre Branch.

Mary is a former board member in the NHS and has been a Trustee of The National Association for the Care and Resettlement of Offenders, and the Society for Companion Animal Studies.

Mary's husband was diagnosed with Parkinson's in 2001. Mary's caring responsibilities have increased over the years, and she understands the importance of finding a cure for Parkinson's and the support needed for everyone affected by the condition.

Mary spent her working life in the public sector with nearly 34 years for the Probation Service in Lancashire, retiring in 2003. In 2001, she was appointed MBE for services to probation in Lancashire and the local community.

Margaret Chamberlain.jpg

Margaret Chamberlain

Margaret Chamberlain was elected to the Board of Trustees in September 2013.

Margaret is a solicitor and a senior partner in a City law firm, with experience of dealing with government, large companies and regulators.

She is passionate about making sure that the voices of people affected by Parkinson's are heard by government, the medical profession and in research.

Margaret has supported Parkinson's UK for many years. Her mother had Parkinson's and she also has a close friend with early onset Parkinson's.


David Allan

David graduated from the University of Stirling in 1985 with an Honours degree in German, having spent two years during his degree studies working and studying in Switzerland, Germany and Austria. The wanderlust first awoken during his student years was to subsequently lead him to spend the next 28 years in various countries in Asia and the Middle East.

David’s Asian sojourn began in Japan, where he spent six years teaching English as a foreign language. He then accepted a position lecturing in English at the International Islamic University in Kuala Lumpur. The next 15 years were to be spent in Malaysia, Singapore and Indonesia and it was during this period that he was to discover his true passion: public relations. His first foray into the world of PR came by way of operations management of Asia’s largest chain of modelling agencies, which led to a four-year stint in event management and concert promotion before joining Malaysia’s largest private tertiary education group as Director of Marketing Communications.

The years 2000 – 2011 were spent managing multinational PR agencies in Malaysia, Indonesia and the UAE. His work in Indonesia was characterised by being primarily focussed on ‘social marketing’. His firm become the first PR agency in Indonesia to have its work recognised by an international industry body, and a number of the communications programmes he devised were acknowledged as establishing new industry benchmarks and were subsequently rolled out in other South-East Asian markets.

David took early retirement in 2012 following his diagnosis with Parkinson’s, having been presenting with symptoms for around six years prior to that. He now busies himself with a variety of voluntary roles not only for Parkinson’s UK, but also for the Children’s Panel and the University of Stirling. David lives in central Scotland with his partner and their golden Labrador, Angus.

Freda Lewis.jpg


Freda Lewis was co-opted to the Board of Trustees in November 2015.

A trained nurse, midwife and health visitor, Freda is a former director of The Fostering Network for Wales and policy manager within the Welsh government. She has extensive experience of the health and social care sectors and the implications of devolution, including legislative differences.

Freda has an MSc in interprofessional studies, researching how professionals work together effectively, and completed a dissertation on effective team work in primary care in 2000.

Freda has supported relatives diagnosed with Parkinson's and is keen to give her knowledge and experience to support people affected by the condition.


Paresh Thakrar

Paresh Thakrar is the Commercial Director of Brit Insurance. He was previously the COO of HiscoxRe and ILS, based in London, driving strategy, technology and operations for the business, and has been pivotal in bringing product, capital and tech innovation into the corporate DNA. Paresh began his career trading emerging markets securities at Deutsche Bank, followed by 7 years as a senior diplomat serving the government as a specialist in global security issues. He then worked at consultants McKinsey & Company where he served a range of investment and retail banks. Paresh holds a BA/MA from the University of Cambridge and an MBA from the London Business School.


Kyle Alexander

Kyle Alexander was appointed by co-option to the Board of Trustees in August 2018. As an urban planner, Kyle has been chief executive and accounting officer of high profile public development corporations in Northern Ireland and brings experience in governance, business planning and project delivery. Kyle received an OBE in 2007 for services to regeneration in Northern Ireland, having overseen the transformation of Belfast's waterfront by Laganside Corporation.

Throughout his career he has been committed to both 'people and place', engaging with local communities to ensure delivery of social outcomes. In recognition of his contribution he accepted the invitation to be a Fellow of the Royal Institute of Chartered Surveyors in 2015. Kyle is a Belfast Harbour Commissioner with a particular interest in corporate social responsibility, a trustee of the community-led Connswater Community Greenway Trust in East Belfast and a trustee of The Waterways Community. He was previously involved in international networks as a board member of the global urban development association INTA and a member of the European CABERNET brownfield regeneration network.

He is a trustee and elder of a local church and currently editor of the church magazine. Married and living in Lisburn, his interests include gardening, supporting Manchester United and playing with 2 young grandchildren. Kyle was diagnosed with Parkinson's in 2016.

Anne MacColl Nov 2016.png

Andrew Caveyn

Andrew Cavey was co-opted to the Board of Trustees in August 2018. He works at Novartis, where he heads the company's clinical development efforts in benign haematology. His role is to help more patients gain access to new and innovative medicines for conditions such as sickle cell disease. Andrew has spent his career in healthcare globally. He worked as a physician for the NHS in the UK and for a variety of non-governmental organisations in conflict and disaster settings in sub-Saharan Africa and Asia. He subsequently became a management consultant at McKinsey & Company, focusing on the pharmaceutical sector, before joining Novartis in various senior strategy and commercial roles in Switzerland and China.

He holds medical and physiology degrees from Oxford University and a Masters in Public Health from Harvard. He lives with his wife and 2 sons in Switzerland.

Tim Tamblyn.jpg

Tim Tamblyn

Tim Tamblyn was originally appointed as the interim Trustee from England in September 2014 but was later elected to this role in September 2015.

Tim is a chartered accountant and is a retired partner of the international accounting and consultancy organisation KPMG.

He is an experienced non-executive director and trustee, and has held non-executive positions in the voluntary sector in social housing, education and the NHS.

Tim cares passionately about the vulnerable people in our society and is a trustee and member of two national charities that support those with learning disabilities.

Tim was diagnosed with Parkinson's in 2012.

Paul Warner.jpg

Paul Warner

Paul Warner was elected to the Board of Trustees in October 2017.

He has an MBA from Henley Management College and is a graduate of the University of Liverpool.

Paul is a chartered accountant and has worked both in practice and industry, retiring from the position of finance director of an SME subsidiary of an international group.

His experience has been varied, covering both commercial operations as well finance.

He is the Treasurer of his local Parkinson's UK branch as well as being a trustee of a pension scheme.

Paul was diagnosed with Parkinson's in 2013 and due to the issues he experienced during diagnosis and treatment he is dedicated to improving the services and support for other people living with Parkinson's.


Gary Shaughnessy

Gary Shaughnessy was elected to the Board of Trustees in August 2018. Gary previously had a successful career in the insurance and financial services industry, working in senior roles within well-known British and international companies. Gary stepped down from his role as CEO Europe, Middle East and Africa for Zurich Insurance in October 2018. Gary is a keen sportsman and played non-league football for many years. Since then he's combined sport and community engagement to raise funds and awareness for both local and national charities. Over the past few years he's thrown himself into wing walking and abseiling, as well as running numerous marathons.

As Chairman of the Zurich's Community Trust he's engaged with companies, governments, charities and academic bodies to help tackle the growing impact of floods globally through early warning and prevention. He's also helped with highlighting the importance of wellbeing, particularly in a digitally enabled world, as well as with finding ways to increase inclusion at work. Gary was diagnosed with Parkinson's in 2015. He decided to step down from his role in Zurich to better balance work and non-executive roles, with spending more time on fitness and with family. He's also able to use his voice and experience to support increased awareness and action for people living with Parkinson's, their families and carers. Gary is married with 3 children.


Matthew Durdy

Part of the team that created the Catapult programme, Matthew Durdy is also an executive director of the Cell and Gene Therapy Catapult. Matthew is responsible for finding, funding and transacting the business of the Catapult as well as the development of the overall strategy. He has been a champion of the early integration of healthcare economics and reimbursement expertise into decision-making and clinical product design in the sector. He began his career in international investment banking and has successfully managed a number of biotechnology SMEs.

His first degree was from Oxford University in Biology and he has an MBA (High Honors) from the University of Chicago Booth School of Business. He is a non-executive director of an immuno-oncology company and periodically assists the government and international organisations in the development of initiatives in healthcare innovation.

David Burn.jpg

David Burn

Professor David Burn took up the position of Pro-Vice-Chancellor of the Faculty of Medical Sciences at Newcastle University on 1st February 2017.

The Faculty delivers impact through excellence in, and close integration of, research, teaching and engagement across seven research institutes and four teaching schools.

David is also Professor of Movement Disorders Neurology and Honorary Consultant Neurologist for Newcastle upon Tyne Hospitals NHS Foundation Trust.

After finishing his first degree at Oxford (Physiological Sciences), he returned to his native North East for clinical training and early medical jobs, including in neurology.

After further neurology training and undertaking research in London (at the National Hospital for Neurology and Neurosurgery, Queen Square and Hammersmith Hospital) he was appointed as a Consultant Neurologist and Senior Lecturer in Newcastle in 1994.

David has an international reputation for research in dementia associated with Parkinson's. He is a NIHR Senior Investigator and Chairs the NIHR Translational Research Collaboration for Dementia.

He served on the Parkinson's UK Research Advisory Panel between 2006 and 2012. As National Clinical Director for the Parkinson's UK Excellence Network between 2014 and 2017, David worked with the Chief Executive and senior charity staff to devise and establish the network, drive innovation, and ensure delivery against key performance indicators.

Beyond this role, David felt highly motivated to retain his connection with Parkinson's UK and to continue to contribute towards delivering the charity's ambitious strategy.

Our Senior Leadership Team

Our senior leadership team is made up of Steve Ford, our chief executive, and nine directors.

Steve Ford.jpg

Steve Ford (Chief Executive)

Steve joined Parkinson's UK as chief executive in 2005 after a career as general manager and chief executive in the NHS.

Under his leadership, we've made significant progress towards our vision to find a cure and improve life for everyone affected by Parkinson's.

Steve believes strongly that change is best delivered in partnership. He's bringing together everyone in the Parkinson's community to speed up research, raise standards of care and empower people affected by the condition to take more control of their lives.

Putting people living with Parkinson's at the heart of the charity has created passion and urgency. Steve believes that is the key to achieving our ambitious goals.

Hanah Burgess.jpg

Hanah Burgess – Director of Finance and Performance

Hanah is the new Director of Finance and Performance at Parkinson’s UK and was previously the Director of Finance and Resources for the blood cancer charity Anthony Nolan. Over her career Hanah has gained extensive commercial and charity experience working in a variety of organisations including PwC, where she qualified as a chartered accountant, Barclays Global Investors and ITV. Hanah is the Treasurer for the AMRC and a Trustee of the children’s rights and development organisation, Plan International UK.

Val Buxton.jpg

VaL Buxton (Director of Strategy Intelligence and Excellence)

Val is passionate about ensuring people affected by Parkinson's influence decision-making.

Her career has focused on improving healthcare and tackling inequalities.

She was Primary Healthcare Editor of Nursing Times, held management roles in the NHS and was Government Nurse for Public Health.

Latterly, she's worked in voluntary sector roles that included responsibility for health policy and service improvement.

Katherine Crawford.jpg

Katherine Crawford (Director of Support and Local Network)

Katherine was born, brought up and educated in Scotland, graduating from Edinburgh University in 1989 with a law degree.

Since then, Katherine’s had a varied career. She practised as a solicitor for a brief time, before owning and running an outdoor events and tourist based company, then taking up a role in adult education.

Katherine joined Parkinson’s UK in 2004 and has used that blend of skills and experience to support in her work. Katherine’s worked in a range of roles at the charity, from direct support for people living with Parkinson’s to leading and managing the charity’s work in Scotland and now leading on our direct support services and local networks across the UK.

Julie Dodd.jpg

Julie Dodd (Director of Digital Transformation and Communication

Julie joined Parkinson's UK in 2016, and is responsible for maximising the potential of digital and technology to transform the lives of people affected by Parkinson's.

She also oversees our broader marketing and communications.

Julie has worked on groundbreaking digital products and strategies for organisations including Macmillan Cancer Support, The Scout Association and Bupa.

She also wrote The New Reality, a major study into how non-profit organisations can approach digital transformation.

Paul Jackson-Clark.jpg

Paul Jackson-Clark (Director of Fundraising)

Director of Fundraising since 2009, Paul has overseen our annual income grow from £16million to £32million.

He's spent more than 20 years in the voluntary sector, cutting his fundraising teeth at a hospice in Liverpool before joining Marie Curie.

Paul is a trustee of the Cavell Nurses' Trust.

Colleen Keck.png

Colleen Keck (General Counsel)

Colleen joined Parkinson's UK in November 2017, and is responsible for legal, contractual and governance matters. Prior to that Colleen was a partner in a major international law firm for over 20 years where she was head of commercial intellectual property practice and co-head of the life sciences practice. Colleen is also Deputy Chair of the Copyright Tribunal, a director of a number of companies and a trustee of the charity Live Music Now.

Carolyn Nutkins.png

Carolyn Nutkins (Director of Organisational Development)

Carolyn leads our teams in human resources, learning and development, central volunteering, internal communications and facilities management.

She has 20 years' human resources experience in private and health/charity roles.

This includes Head of HR at the Royal College of GPs and HR and Training Manager at Nuffield Hospitals.

Arthur Roach.jpg

Dr Arthur Roach (Director of Research)

Responsible for strategically driving better treatments for people with Parkinson's, Arthur has spent 25 years in research, discovery and development for drug companies and universities.

He's been lead biologist on projects developing new treatments for Alzheimer's, Parkinson's and MS.

He's also led evaluations of more than 100 drug discovery partnerships as Senior Director at Merck Serono.